Home › Prescription medicine › Legacy Pharmaceutical Packaging LLC —…
Legacy Pharmaceutical Packaging LLC — Sertraline Tablets, USP 100 mg, 30 tablets per bottle
Do not stop taking this without speaking to your pharmacist or doctor.
What’s wrong
CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.
The Recall Registry rates this serious — FDA Class II: temporary or medically reversible health harm.
What to do
Check the lot numbers below against what you have. Do not stop taking a prescription medicine because of a recall without speaking to your pharmacist or doctor first — for many medicines stopping is more harmful than continuing, and they can tell you whether yours is affected and what to do about it.
Who to contact: Recalling firm: Legacy Pharmaceutical Packaging LLC
The product
Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54
Details
- Units affected
- 161,664 bottles
- Recall date
- December 11, 2023
- Brand
- Legacy Pharmaceutical Packaging LLC
CA and AR
The official notice
This recall was issued by the U.S. Food and Drug Administration. The Recall Registry summarises it — always confirm the details at the source.
Their exact wording: “Legacy Pharmaceutical Packaging LLC — Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging”
Worried about the other things in your house? You can write down what you have and be told if one is recalled — or, if you sell second-hand, check your whole stock at once.
Filed under: Prescription medicine